These data collectively suggest that CFM-4 and CFM-5 signaling likely overlap with ADR in down-regulating key cell proliferation and survival regulating genes to inhibit growth of the NB cells, and both the compounds are superior in suppressing MYCN expression when compared with ADR. The gene discussed is MYCN; the disease is neuroblastoma.